Developing the first medical device to support preterm infant neurodevelopmental. Our technology utilizes recorded maternal voice. Published studies show accelerated brain development.
NIH funding for product dev, pivotal study (enrolling) and regulatory.
Non-regulated version ready to launch to hospitals and to parents. Pilots will convert to first customers.
High margin $1B plus opportunity. No direct competition. Patents issued and pending.